Ashfield Capital Partners, LLC Johnson & Johnson Transaction History

Ashfield Capital Partners, LLC

$1.19 Billion
Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 95,026 shares of JNJ stock, worth $14.7 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

95,026

Previous 96,017 1.03%

Holding current value

$14.7 Million

Previous $17 Million 8.92%

% of portfolio

1.3%

Previous 1.33%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $159,878 - $177,904	-991 Reduced 1.03%	95,026 $15.5 Million
Q2 2022 Jul 29, 2022	SELL	$168.19 - $186.01 $124,292 - $137,461	-739 Reduced 0.76%	96,017 $17 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $76,697 - $87,101	-485 Reduced 0.5%	96,756 $17.1 Million
Q4 2021 Feb 02, 2022	SELL	$155.93 - $173.01 $1,871 - $2,076	-12 Reduced 0.01%	97,241 $16.6 Million
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $144,542 - $160,625	-895 Reduced 0.91%	97,253 $15.7 Million
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $96,006 - $102,984	602 Added 0.62%	98,148 $16.2 Million
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $176,642 - $196,733	-1,154 Reduced 1.17%	97,546 $16 Million
Q4 2020 Feb 02, 2021	SELL	$137.11 - $157.38 $17,412 - $19,987	-127 Reduced 0.13%	98,700 $15.5 Million
Q3 2020 Nov 03, 2020	SELL	$140.38 - $153.83 $79,314 - $86,913	-565 Reduced 0.57%	98,827 $14.7 Million
Q2 2020 Aug 05, 2020	SELL	$128.81 - $155.51 $171,961 - $207,605	-1,335 Reduced 1.33%	99,392 $14 Million
Q1 2020 May 06, 2020	SELL	$111.14 - $153.99 $60,349 - $83,616	-543 Reduced 0.54%	100,727 $13.2 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $619,140 - $711,112	-4,856 Reduced 4.58%	101,270 $14.8 Million
Q3 2019 Oct 31, 2019	SELL	$126.95 - $142.14 $65,760 - $73,628	-518 Reduced 0.49%	106,126 $13.7 Million
Q2 2019 Jul 29, 2019	SELL	$131.15 - $144.24 $47,476 - $52,214	-362 Reduced 0.34%	106,644 $14.9 Million
Q1 2019 Apr 30, 2019	SELL	$125.72 - $139.79 $55,819 - $62,066	-444 Reduced 0.41%	107,006 $15 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $129,104 - $155,379	1,051 Added 0.99%	107,450 $13.9 Million
Q3 2018 Nov 02, 2018	SELL	$121.58 - $142.88 $242,795 - $285,331	-1,997 Reduced 1.84%	106,399 $14.7 Million
Q2 2018 Jul 26, 2018	SELL	$119.4 - $131.76 $4,537 - $5,006	-38 Reduced 0.04%	108,396 $13.2 Million
Q1 2018 May 02, 2018	SELL	$125.1 - $148.14 $53,793 - $63,700	-430 Reduced 0.39%	108,434 $13.9 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $71,121 - $77,842	-542 Reduced 0.5%	108,864 $15.2 Million
Q3 2017 Nov 07, 2017	SELL	$129.47 - $135.38 $14,759 - $15,433	-114 Reduced 0.1%	109,406 $14.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	109,520	109,520 $14.5 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Account

Ashfield Capital Partners, LLC Johnson & Johnson Transaction History